Renal Cancer
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.
August 28, 2024
APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression.
August 28, 2024
The influence of sex hormones on renal cell carcinoma.
August 26, 2024
Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma.
August 26, 2024
Exploring the Feasibility of GPT-4 as a Data Extraction Tool for Renal Surgery Operative Notes.
August 26, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau".
August 26, 2024
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort.
August 26, 2024
Avelumab plus axitinib for first-line treatment of advanced renal cell carcinoma: A real-world ambispective RAVE-Renal study.
August 22, 2024
Navigating the Nuances: Evaluating Avelumab and Axitinib in Metastatic Renal Cell Carcinoma Treatment
August 22, 2024
Prognostic assessment of patients with bone metastatic renal cell cancer treated with palliative radiotherapy.
August 22, 2024
The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis.
August 22, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
August 22, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.
August 21, 2024